cinacalcet hydrochloride

Spain

Drugs containing this active substance

  • CINACALCET ACCORDPHARMA 30 MG FILM-COATED TABLETS EFG

    It is used to treat disorders of the parathyroid glands, helping to control levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, and to reduce high calcium levels in the blood (hypercalcemia) in cases of parathyroid cancer or primary hyperparathyroidism.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 33 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Accord Healthcare S.L.U.

  • It is used to treat disorders of the parathyroid glands, helping to control levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, and to reduce high calcium levels in the blood in cases of parathyroid cancer or primary hyperparathyroidism. In children between 3 and 18 years of age, it is used for secondary hyperparathyroidism related to severe kidney disease.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 66.00 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Accord Healthcare S.L.U.

  • It is used to treat disorders of the parathyroid glands, helping to control levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, and to reduce high calcium levels in the blood in cases of parathyroid cancer or primary hyperparathyroidism.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 99.00 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Accord Healthcare S.L.U.

  • It is used to treat disorders of the parathyroid glands, helping to control levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it treats secondary hyperparathyroidism in people with severe kidney disease who require dialysis, and reduces high levels of calcium in the blood in cases of parathyroid cancer or primary hyperparathyroidism.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 33.06 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Aurovitas Spain, S.A.U.

  • It is used to treat disorders of the parathyroid glands, helping to control levels of parathyroid hormone (PTH), calcium, and phosphorus. It is prescribed in adults for secondary hyperparathyroidism (in patients with severe kidney disease requiring dialysis), to reduce high blood calcium caused by parathyroid cancer or primary hyperparathyroidism. In children aged 3 to less than 18 years, it is used for secondary hyperparathyroidism related to severe kidney disease.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 66.13 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Aurovitas Spain, S.A.U.

  • It is used to treat disorders of the parathyroid glands, helping to control levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, and to reduce high calcium levels in the blood in cases of parathyroid cancer or primary hyperparathyroidism.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 99.19 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Aurovitas Spain, S.A.U.

  • It is used to treat disorders of the parathyroid glands, such as secondary hyperparathyroidism in adults with severe kidney disease requiring dialysis, or to reduce high calcium levels in the blood in patients with parathyroid cancer or primary hyperparathyroidism.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 33,063 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Macleods Pharma Espana S.L.U.

  • It is used to treat disorders of the parathyroid glands, such as secondary hyperparathyroidism in adults with severe kidney disease requiring dialysis, or to reduce high calcium levels in the blood (hypercalcemia) in patients with parathyroid cancer or primary hyperparathyroidism.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 66,127 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Macleods Pharma Espana S.L.U.

  • It is used to treat disorders of the parathyroid glands, controlling levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it treats secondary hyperparathyroidism in patients with severe kidney disease who require dialysis, and to reduce high levels of calcium in the blood due to parathyroid cancer or primary hyperparathyroidism. In children between 3 and 18 years of age, it is used for secondary hyperparathyroidism associated with severe kidney disease.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 99,19 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Macleods Pharma Espana S.L.U.

  • It is used to treat disorders of the parathyroid glands by controlling levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, or to reduce high blood calcium levels caused by parathyroid cancer or primary hyperparathyroidism. In children aged 3 to less than 18 years, it is used for secondary hyperparathyroidism related to severe kidney disease.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 33,06 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Laboratorios Normon S.A.

  • It is used to treat disorders of the parathyroid glands by controlling parathyroid hormone (PTH), calcium, and phosphorus levels. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, or to reduce high blood calcium levels caused by parathyroid cancer or primary hyperparathyroidism. In children aged 3 to less than 18 years, it is used for secondary hyperparathyroidism due to severe kidney disease.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 66,12 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Laboratorios Normon S.A.

  • It is used to treat disorders of the parathyroid glands by controlling levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, or to reduce high blood calcium levels caused by parathyroid cancer or primary hyperparathyroidism. In children aged 3 to less than 18 years, it is used for secondary hyperparathyroidism related to severe kidney disease.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 99,18 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Laboratorios Normon S.A.

  • What is Cinacalcet STADA used for?": "It is used to treat parathyroid gland disorders by controlling parathyroid hormone (PTH), calcium, and phosphorus levels. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, and to reduce high calcium levels in the blood in cases of parathyroid cancer or primary hyperparathyroidism.",

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 33,07 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Laboratorio Stada S.L.

  • It is used to treat disorders of the parathyroid glands by controlling parathyroid hormone (PTH), calcium, and phosphorus levels. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, and to reduce high calcium levels in the blood in patients with parathyroid cancer or primary hyperparathyroidism. In children between 3 and 18 years of age, it is used for secondary hyperparathyroidism related to severe kidney disease that is not controlled by other treatments.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 66.133 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Laboratorio Stada S.L.

  • It is used to treat disorders of the parathyroid glands by controlling levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it is used to treat secondary hyperparathyroidism in patients with severe kidney disease who require dialysis, or to reduce high blood calcium levels caused by parathyroid cancer or primary hyperparathyroidism. In children aged 3 to less than 18 years, it is used for secondary hyperparathyroidism due to severe kidney disease that is not controlled by other treatments.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 99.200 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Laboratorio Stada S.L.

  • It is used to treat disorders of the parathyroid glands by controlling levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it is used to treat secondary hyperparathyroidism in patients with severe kidney disease who require dialysis, and to reduce high blood calcium levels in cases of parathyroid cancer or primary hyperparathyroidism.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 33,064 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Tarbis Farma S.L.

  • It is used to treat disorders of the parathyroid glands by controlling levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, and to reduce high calcium levels in the blood in cases of parathyroid cancer or primary hyperparathyroidism.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 66,127 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Tarbis Farma S.L.

  • It is used to treat disorders of the parathyroid glands by controlling the levels of parathyroid hormone (PTH), calcium, and phosphorus. In adults, it is used to treat secondary hyperparathyroidism in people with severe kidney disease who require dialysis, and to reduce high calcium levels in the blood in cases of parathyroid cancer or primary hyperparathyroidism.

    Form: tablets, film-coated

    Active substance Dosage
    cinacalcet hydrochloride 99,191 mg

    ATC: H05B H05BX H05BX01

    Manufacturer: Tarbis Farma S.L.